The Motley Fool

Roland Head

Roland is an experienced investment writer and analyst with a focus on quality, income and value. He's been writing for the Motley Fool since 2012 and also contributes to a number of other private investor platforms. He holds the CFA UK Investment Management Certificate (IMC) and has passed the CFA Level 1 exam. A keen private investor, he also runs an internet business.

Can the Kier share price continue to surge higher?

Roland Head is impressed with turnaround progress at Kier, but his analysis suggests that Kier's share price might not be as cheap as it... More »

3 of the best FTSE 100 stocks to buy today

Roland Head explains why he thinks these FTSE 100 stocks should perform well this year, even if the economic outlook remains uncertain. More »

UDG shares soar on takeover bid. Here’s another healthcare stock I’d buy now

The UDG share price is up on takeover news. But Roland Head also looks at another healthcare stock he sees as a bid target. More »

The FTSE 100 is falling: three 7% dividend yield shares I’d buy now

These FTSE 100 high dividend yield shares could be a great way to protect against the risk of a falling market, reckons Roland Head. More »

The Provident Financial share price is crashing: should I buy?

The Provident Financial share price is down by 30% so far this year as the firm battles problems at its door-to-door lending business. More »

2 UK shares I think Warren Buffett would buy today

Roland Head explains why these successful UK shares are on his buy list -- and why he thinks the 'Oracle of Omaha' might also... More »

Is the IAG share price still cheap enough to buy?

The IAG share price has soared since November. Roland Head reviews the latest numbers and explains why he's not buying this reopening stock. More »

As the Meggitt share price soars, have I left it too late to buy?

The Meggitt share price has doubled in 12 months and is surging higher on bid rumours. Roland Head explains why he still likes this... More »

The ITM Power share price is down 30%. Should I buy now?

The ITM Power share price is down by 30% in a month. Roland Head revisits the news and asks what's gone wrong for the... More »

If I could only buy one tech share, this would be it

This founder-backed UK tech share has lagged the FTSE 100 this year. Roland Head explains why he thinks it could be a long-term winner. More »

The Darktrace share price is up 30%. Should I buy the stock now?

The Darktrace share price has soared since the firm's flotation. Roland Head explains why he's attracted to this cyber security business. More »

If I could only buy 1 UK share, this would be it

This UK share ticks all the boxes for our writer, who explains why this unfashionable firm has outperformed many trendier rivals. More »

2 ESG investing stocks I’d buy right now

Roland Head explains his approach to picking stocks for ESG investing and chooses two he thinks could make a positive contribution. More »

Will the Rolls-Royce share price soar in May?

Will the Rolls-Royce share price surge higher as flying restrictions are lifted? Roland Head explains why he thinks this FTSE 100 stock offers value. More »

UK shares to buy for May: how I’d invest £2,000 today

After a strong market rally, which UK shares still deserve a 'buy' rating? Roland Head looks at two stocks he thinks are poised for... More »

Will the GSK share price keep climbing in May?

GSK's share price is up from its March lows, but the firm is still the biggest FTSE 100 faller over 12 months. Roland Head... More »

Travis Perkins and Mulberry are today’s big share-price movers: here’s why

Travis Perkins and Mulberry issued market-moving updates today. Roland Head explains the impact on each company's share price. More »

Passive income: 2 FTSE 100 shares I’d buy now

Roland Head reveals two FTSE 100 stocks he's been buying for passive income. One of these firms hasn't cut its dividend for 55 years. More »

The Tristel share price crashes on a profit warning: should I buy?

The Tristel share price is crashing after the medical disinfectant specialist warned of a big fall in profits due to the impact of Covid-19. More »

The Novacyt share price is flying. Should I buy the rebound?

The Novacyt share price is up by more than 15% today and the company has a number of new products. Roland Head asks if... More »